Clinical Trial Update: Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer [NA]

View source ↗

Summary

A pilot neoadjuvant trial combining chemotherapy, immunotherapy, and multimodal thermal therapy for HER2-negative breast cancer is currently recruiting at Fudan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer Female, HER2-negative Breast Cancer | NA | Status: RECRUITING